Main finding: Topical ocular hypotensive medication was effective in delaying or preventing the onset of POAG in individuals with elevated IOP; At 60 months, the cumulative probability of developing POAG was 4.4% in the medication group and 9.5% in the observation group.
- Purpose: To determine the safety and efficacy of topical ocular hypotensive medication in delaying or preventing the onset of POAG.
- Study type: Randomized controlled trial
- Condition: Ocular Hypertension
Source Archive